Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: A randomized double-blind placebo-controlled trial

American Journal of Gastroenterology

Volumn 104, Issue 3, 2009, Pages 617-623

  Abid, Shahab ^a,b   Jafri, Wasim ^a   Hamid, Saeed ^a   Salih, Mohammad ^a   Azam, Zahid ^a   Mumtaz, Khalid ^a   Shah, Hasnain Ali ^a   Abbas, Zaigham ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; OCTREOTIDE; PLACEBO; TERLIPRESSIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; ESOPHAGUS HEMORRHAGE; FEMALE; GASTRIC SUCTION; GASTROINTESTINAL ENDOSCOPY; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DOUBLE-BLIND METHOD; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; LENGTH OF STAY; LIGATION; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; OCTREOTIDE; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 62049083402     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.147     Document Type: Article

References (19)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.
2. de Franchis R, The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983-9.
3. D'Amico G, Pietrosi G, Tarantino I et al. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003;124:1277-91.
4. de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-7
5. Escorsell A, Arbol LRD, Planas R et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000;32:471-6.
6. Bildozola M, Kravetz D, Argonz J et al. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand J Gastroenterol 2000;35:419-25.
7. Besson I, Ingrand P, Person B et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
8. Ottesen LH, Flyvbjerg A, Møller S et al. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients. Aliment Pharmacol Ther 1998;12:657-65.
9. de Franchis R. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding esophageal varices. Dig Liver Dis 2004;36 (Suppl 1): S93-100.
10. Burroughs AK. Pharmacological treatment of acute variceal bleeding. Digestion 1998;59 (Suppl 2): 28-36.
11. Douglas JG, Forrest JA, Prowse CV et al. Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis. Gut 1979;20:565-7.
12. Cales P, Masliah C, Bernard B et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension. N Engl J Med 2001;344:23-28.
13. Banares R, Albillos A, Rincon D et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002;35:609-15.
14. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
15. Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol 2000;95:768-71.
16. Gross M, Scheimann U, Muhlhofer A et al. Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 2001;33:737-46.
17. Campisi C, Padula P, Peressini A et al. Upper digestive hemorrhage. Comparison of terlipressin and octreotide. Minerva Chir 1993;48:1091-6 (Article in Italian).
18. Feu F, Ruiz del Arbol L, Bana res R et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology 1996;111:1291-9.
19. Ioannou G, Douost J, Rocky DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;1:CD002147.